Dr. Bibat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
707 North Broadway
Baltimore, MD 21205Phone+1 443-923-2697Fax+1 443-923-9515
Education & Training
- University of Santo TomasClass of 1987
Clinical Trials
- Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Start of enrollment: 2010 Sep 01
- A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects Start of enrollment: 2013 May 01
- Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) Start of enrollment: 2020 Dec 15
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsA phase Ib/IIa, open-label, multiple ascending-dose trial of domagrozumab in fukutin-related protein limb-girdle muscular dystrophy.Doris G. Leung, Alex E. Bocchieri, Shivani Ahlawat, Michael A. Jacobs, Vishwa S. Parekh
Muscle & Nerve. 2021-05-24 - 8 citationsLongitudinal functional and imaging outcome measures in FKRP limb-girdle muscular dystrophy.Doris G. Leung, Alex E. Bocchieri, Shivani Ahlawat, Michael A. Jacobs, Vishwa S. Parekh
BMC Neurology. 2020-05-19 - 11 citationsThe NIH Toolbox for cognitive surveillance in Duchenne muscular dystrophyMathula Thangarajh, Aaron J. Kaat, Genila Bibat, Jennifer Mansour, Katherine Summerton
Annals of Clinical and Translational Neurology. 2019-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: